ÐÂÎÅ×ÊѶ
918²©ÌìÌÃÔÑÐÒ©MCR»·ëÄ¿ª·¢ÌÇÄò²¡ÊÓÍøĤ²¡±ä¶àͨ·ÖÎÁÆÐÂÕ½ÂÔ£¬£¬£¬£¬£¬£¬ £¬Í»ÆÆ¿¹VEGFÒ©Îï¾ÖÏÞ½ø¾üDZÔÚÊý°ÙÒÚÐÂÈüµÀ
ÈÕÆÚ£º
2026Äê04ÔÂ02ÈÕ 15:00
ÌÇÄò²¡ÊÓÍøĤ²¡±ä£¨DR£©ÊÇÌÇÄò²¡×î³£¼ûÇÒÑÏÖصÄ΢Ѫ¹Ü²¢·¢Ö¢Ö®Ò»£¬£¬£¬£¬£¬£¬ £¬Ò²ÊǸ÷ÄêËêÈËȺ£¨°üÀ¨¶ùͯ¡¢ÊÂÇé³ÉÄêÈ˺ÍÍíÄêÈË£©Ö÷ÒªµÄÖÂäԵ¹ÊÔÓÉ1 ¡£¡£¡£¡£¡£¡£¡£¡£2020Ä꣬£¬£¬£¬£¬£¬ £¬È«ÇòÓÐÁè¼Ý1.03ÒÚÈËÊܵ½ÌÇÄò²¡ÊÓÍøĤ²¡±äµÄÓ°Ï죬£¬£¬£¬£¬£¬ £¬Ô¤¼Æµ½2045ÄêÕâÒ»Êý×Ö½«ÉÏÉýµ½1.61ÒÚÈË1 ¡£¡£¡£¡£¡£¡£¡£¡£ÕâÒ»ÑÓÐø¶àÄêµÄÁÙ´²ðó¼²£¬£¬£¬£¬£¬£¬ £¬Õý±»Ò»ÏîÖйúÔ´´Í»ÆÆËùº³¶¯ ¡£¡£¡£¡£¡£¡£¡£¡£¿ËÈÕ£¬£¬£¬£¬£¬£¬ £¬¾ÝϤ918²©ÌìÌã¨ÒÔϼò³Æ“918²©ÌìÌÔ£©×ÔÖ÷Ñз¢µÄÁ¢ÒìС·Ö×Ó»·ëÄÒ©ÎMCR»·ëÄ£©ÔÚÌÇÄò²¡ÊÓÍøĤ²¡±äÖÎÁÆÁìÓòÈ¡µÃÁÙ´²Ç°ÖØ´óÍ»ÆÆ ¡£¡£¡£¡£¡£¡£¡£¡£
Ò»¡¢ÌÇÄò²¡ÊÓÍøĤ²¡±äµÄÖÎÁÆÄæ¾³
ÌÇÄò²¡ÊÓÍøĤ²¡±äÊÇÒ»ÖÖÏ£ÍûÐÔÑÛ²¿¼²² ¡£¡£¡£¡£¡£¡£¡£¡£¬£¬£¬£¬£¬£¬ £¬ºã¾Ã¸ßѪÌǻᵼÖÂÊÓÍøĤ΢Ѫ¹ÜËðÉË£¬£¬£¬£¬£¬£¬ £¬Òý·¢ÊÓÍøĤȱѪȱÑõ£¬£¬£¬£¬£¬£¬ £¬½ø¶øÔö½ø²¡ÀíÐÔÐÂÉúѪ¹ÜÐγɣ¬£¬£¬£¬£¬£¬ £¬Ôì³ÉÊÓÍøĤÔöÖ³ÐÔ²¡±ä2 ¡£¡£¡£¡£¡£¡£¡£¡£ÏÖÔÚ£¬£¬£¬£¬£¬£¬ £¬¿¹VEGFÒ©ÎïºÍ¼¤¹â¹âÄýÊõÊÇÖÎÁÆDRµÄ½ð±ê×¼ÁÆ·¨£¬£¬£¬£¬£¬£¬ £¬µ«±£´æÐèҪƵÈÔÑÛÄÚ×¢Éä¡¢²¿·Ö»¼ÕßÓ¦´ð²»¼ÑµÈÎÊÌ⣬£¬£¬£¬£¬£¬ £¬Ø½ÐèÐÂÐÍÖÎÁÆÕ½ÂÔ1 ¡£¡£¡£¡£¡£¡£¡£¡£
½üÄêÀ´µÄÑо¿·¢Ã÷£¬£¬£¬£¬£¬£¬ £¬ºÚƤÖÊËØϵͳ£¨Melanocortin System£©ÔÚµ÷ÀíÑ×Ö¢·´Ó¦¡¢Ôö½ø×éÖ¯ÐÞ¸´ºÍά³ÖÄÚÇéÐÎÎȹ̷½ÃæÊ©Õ¹Òªº¦×÷ÓÃ3£¬£¬£¬£¬£¬£¬ £¬ÎªDRÖÎÁÆÌṩÁËÐÂ˼Ð÷ ¡£¡£¡£¡£¡£¡£¡£¡£
¶þ¡¢918²©ÌìÌÃMCR»·ëÄ£º¶ÔÊÓÍøĤ½á¹¹±£» £»£»£»£»£»£»¤Ð§¹ûÏÔÖø
918²©ÌìÌÃÑз¢µÄMCR»·ëÄÔÚDB/DBÌÇÄò²¡Ð¡ÊóÄ£×ÓÖÐÌåÏÖ³öÏÔÖøµÄÊÓÍøĤ±£» £»£»£»£»£»£»¤×÷Óà ¡£¡£¡£¡£¡£¡£¡£¡£
ʵÑéЧ¹ûÏÔʾ£¬£¬£¬£¬£¬£¬ £¬DB/DBÄ£×ÓСÊóµÄÄں˲㣨INL£©ºÍÍâºË²ã£¨ONL£©ºñ¶ÈÏÔ×Å±ä± ¡£¡£¡£¡£¡£¡£¡£¡£¬£¬£¬£¬£¬£¬ £¬ÕâÊÇÌÇÄò²¡ÒýÆðÊÓÍøĤ±äÐԵĵ䷶ÌØÕ÷ ¡£¡£¡£¡£¡£¡£¡£¡£¶ø¾ÓÉMCR»·ëÄÖÎÁƺ󣬣¬£¬£¬£¬£¬ £¬ÊÓÍøĤ½á¹¹»ñµÃÏÔןÄÉÆ£º
1. MCR»·ëĵͼÁÁ¿×éºÍ¸ß¼ÁÁ¿×éÏÔʾ¼ÁÁ¿ÒÀÀµÐÔµÄÊÓÍøĤ½á¹¹»Ö¸´£» £»£»£»£»£»£»
2. MCR»·ëĸ߼ÁÁ¿×éµÄONLºñ¶È»Ö¸´¿¿½üÕý³£Ë®Æ½ ¡£¡£¡£¡£¡£¡£¡£¡£
Èý¡¢¶àÖØ»úÖÆÐͬ×÷ÓÃ
918²©ÌìÌÃMCR»·ëĵĽ¹µãÓÅÊÆÔÚÓÚÆä¶à°Ðµã×÷ÓûúÖÆ ¡£¡£¡£¡£¡£¡£¡£¡£ËüÄ£ÄâÁËÄÚÔ´ÐÔºÚƤÖÊËØ£¨Èçα- MSH£©µÄÐÄÀí¹¦Ð§£¬£¬£¬£¬£¬£¬ £¬Í¨¹ý¼¤»îÑÛÖеĺÚƤÖÊËØÊÜÌ壬£¬£¬£¬£¬£¬ £¬´ÓÑ×Ö¢¡¢Ñª¹Ü¡¢ÆÁÕϺÍÉñ¾µÈ¶à¸öÒªº¦»·½ÚÐͬʩչ×÷ÓÃ1, 4 ¡£¡£¡£¡£¡£¡£¡£¡£
ǿЧ¿¹Ñ×ÓëÃâÒßµ÷Àí
ÌÇÄò²¡ÊÓÍøĤ²¡±äʵÖÊÉÏÊÇÒ»ÖÖÂýÐԵͶÈÑ×Ö¢ÐÔ¼²²¡ ¡£¡£¡£¡£¡£¡£¡£¡£Ñо¿Ö¤Êµ£¬£¬£¬£¬£¬£¬ £¬¼¤»îMCR£¬£¬£¬£¬£¬£¬ £¬ÌØÊâÊÇMC1R£¬£¬£¬£¬£¬£¬ £¬Äܹ»ÏÔÖøÒÖÖƺËÒò×ÓκB£¨NF-κB£©µÈÒªº¦´ÙÑ×ÐźÅͨ·µÄ»î»¯5 ¡£¡£¡£¡£¡£¡£¡£¡£Õâµ¼Ö¶àÖÖ´ÙÑ×Òò×Ó£¨ÈçTNF-α, IL-1β, IL-6£©ºÍÇ÷»¯Òò×Ó£¨ÈçMIP-1α, MIP-2£©µÄ±í´ïϵ÷4 ¡£¡£¡£¡£¡£¡£¡£¡£¸üÖ÷ÒªµÄÊÇ£¬£¬£¬£¬£¬£¬ £¬MCR¼¤¶¯¼ÁÄÜÓÕµ¼¾ßÓп¹Ñ×¹¦Ð§µÄµ÷ÀíÐÔTϸ°û£¨Treg£©µÄÌìÉú£¬£¬£¬£¬£¬£¬ £¬²¢Ôö½ø¿¹Ñ×ϸ°ûÒò×ÓIL-10µÄ±í´ï£¬£¬£¬£¬£¬£¬ £¬´Ó¶ø½«ÃâÒß·´Ó¦´ÓÆÆËðÐԵĴÙÑ×״̬תÏò±£» £»£»£»£»£»£»¤ÐԵĿ¹Ñ׺ÍÐÞ¸´×´Ì¬4, 5 ¡£¡£¡£¡£¡£¡£¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬ £¬ÔÚÌÇÄò²¡ÊÓÍøĤ²¡±äÄ£×ÓÖУ¬£¬£¬£¬£¬£¬ £¬MCR¼¤¶¯¼Á»¹±»Ö¤Êµ¿ÉÒÔÔö½ø¾ÞÊÉϸ°û´Ó´ÙÑ×µÄM1±íÐÍÏò¿¹Ñס¢´ÙÐÞ¸´µÄM2±íÐͼ«»¯£¬£¬£¬£¬£¬£¬ £¬ÕâÓÐÖúÓÚÑ×Ö¢µÄÏûÍ˺Í×éÖ¯ÐÞ¸´4 ¡£¡£¡£¡£¡£¡£¡£¡£
¿¹Ñª¹ÜÌìÉúÓë¼õÇáÉø©
³ýÁËÒÖÖÆÑ×Ö¢£¬£¬£¬£¬£¬£¬ £¬MCR¼¤¶¯¼ÁÄܹ»Ö±½Ó×÷ÓÃÓÚѪ¹Üϵͳ ¡£¡£¡£¡£¡£¡£¡£¡£Ñо¿Åú×¢£¬£¬£¬£¬£¬£¬ £¬¼¤»îMC4R¿ÉÒÔÞ׿¹ÊÓÍøĤ΢Ѫ¹ÜÄÚƤϸ°ûµÄ¸ßͨ͸ÐÔ5 ¡£¡£¡£¡£¡£¡£¡£¡£Í¬Ê±£¬£¬£¬£¬£¬£¬ £¬¼¤¶¯MC1RÄÜÏÔÖø½µµÍÊÓÍøĤÖÐѪ¹ÜÄÚƤÉú³¤Òò×Ó£¨VEGF£©µÄˮƽ£¬£¬£¬£¬£¬£¬ £¬ÕâÊÇÇý¶¯²¡ÀíÐÔÐÂÉúѪ¹ÜÐγɺÍѪ¹ÜÉø©µÄÒªº¦Òò×Ó4 ¡£¡£¡£¡£¡£¡£¡£¡£ÕâÖÖͨ¹ýµ÷ÀíÄÚÔ´ÐÔͨ·À´ÒÖÖÆVEGFµÄÆæÒì»úÖÆ£¬£¬£¬£¬£¬£¬ £¬ÓëÏÖÓеĿ¹VEGFÒ©ÎïÐγɻ¥²¹£¬£¬£¬£¬£¬£¬ £¬¿ÉÄÜΪ½â¾ö¿¹VEGFÖÎÁÆÄÍÒ©ÐÔÎÊÌâÌṩÐÂÕ½ÂÔ ¡£¡£¡£¡£¡£¡£¡£¡£
ÎȹÌѪ-ÊÓÍøĤÆÁÕÏ
Ѫ-ÊÓÍøĤÆÁÕϵÄÆÆËðÊÇÌÇÄò²¡ÊÓÍøĤ²¡±äѪ¹ÜÉø©ºÍÊÓÍøĤˮÖ׵IJ¡Àí»ù´¡ ¡£¡£¡£¡£¡£¡£¡£¡£MCR¼¤»î¿ÉÏÔÖøÔöÌíÊÓÍøĤÖÐϸÃÜÅþÁ¬ÂÑ°×£¨ÈçOccludin£©µÄ±í´ï£¬£¬£¬£¬£¬£¬ £¬´Ó¶ø´Ó½á¹¹ÉϼӹÌѪ-ÊÓÍøĤÆÁÕÏ£¬£¬£¬£¬£¬£¬ £¬ïÔÌѪ½¬ÒòËصÄÉø©4 ¡£¡£¡£¡£¡£¡£¡£¡£
Ö±½Óϸ°û±£» £»£»£»£»£»£»¤Ó뿹µòÍö
MCRµÄϸ°û±£» £»£»£»£»£»£»¤×÷ÓÃÓâÔ½ÁËѪ¹ÜºÍÑ×֢ϸ°û£¬£¬£¬£¬£¬£¬ £¬Ö±½Ó»Ý¼°ÊÓÍøĤÉñ¾Ôª ¡£¡£¡£¡£¡£¡£¡£¡£α-MSHÒѱ»Ö¤ÊµÄܹ»Í¨¹ý¼¤»îMC1R¼°ÆäÏÂÓεÄAkt/mTORºÍErk1/2 MAPKÐźÅͨ·£¬£¬£¬£¬£¬£¬ £¬±£» £»£»£»£»£»£»¤ÊÓÍøĤɫËØÉÏƤϸ°ûÃâÊÜÑõ»¯Ó¦¼¤ÓÕµ¼µÄµòÍö5 ¡£¡£¡£¡£¡£¡£¡£¡£ÔÚȱѪ/ÔÙ¹à×¢ËðÉËÄ£×ÓÖУ¬£¬£¬£¬£¬£¬ £¬MCR¼¤¶¯¼ÁÏÔʾ³ö¶ÔÊÓÍøĤÉñ¾½Úϸ°ûµÄÏÔÖø±£» £»£»£»£»£»£»¤×÷Ó㬣¬£¬£¬£¬£¬ £¬ïÔÌϸ°ûµòÍö£¬£¬£¬£¬£¬£¬ £¬Õâ¹ØÓÚ±ÜÃâÌÇÄò²¡ÊÓÍøĤ²¡±äÖеÄÉñ¾±äÐÔÖÁ¹ØÖ÷Òª ¡£¡£¡£¡£¡£¡£¡£¡£
ËÄ¡¢Ô¶¾°Õ¹Íû
ÌÇÄò²¡ÊÓÍøĤ²¡±äµÄÖÎÁÆÕý´¦ÔÚÒ»¸öתÐÍÆÚ£¬£¬£¬£¬£¬£¬ £¬´Ó¼òµ¥µÄVEGFÒÖÖÆÏò¶à°Ðµã¡¢È«·½Î»±£» £»£»£»£»£»£»¤µÄÆ«ÏòÉú³¤ ¡£¡£¡£¡£¡£¡£¡£¡£918²©ÌìÌõÄMCR»·ëÄÒ©ÎïÒÀ¸½ÆäÆæÒìµÄ×÷ÓûúÖƺÍÁîÈ˹ÄÎèµÄÁÙ´²Ç°Êý¾Ý£¬£¬£¬£¬£¬£¬ £¬ÓÐÍû³ÉΪÕâÒ»ÁìÓòµÄÖØ°õ²úÆ·£¬£¬£¬£¬£¬£¬ £¬ÎªÈ«ÇòÊýÒÚDR»¼Õß´øÀ´ÐµÄÖÎÁÆÑ¡Ôñ ¡£¡£¡£¡£¡£¡£¡£¡£
ÎÄÕÂȪԴÓÚҩʱ´ú¹«ÖÚºÅ
²Î¿¼ÎÄÏ×
1. Seo, H., Park, S. J., & Song, M. (2025). Diabetic Retinopathy (DR): Mechanisms, Current Therapies, and Emerging Strategies. Cells, 14(5), 376. https://doi.org/10.3390/cells14050376
2. áÓÖÝÉòÊÏÑÛ¿ÆÒ½Ôº£¨2024£©. ÌÇÄò²¡ÐÔÊÓÍøĤ²¡±ä¿ÆÆÕ. ΢ÐŹ«ÖÚºÅ. Available at:https://mp.weixin.qq.com/s?__biz=MzA5NDI4NTcyNw==&mid=2653585500&idx=1&sn=87cf362b3300a3db891c4c19b8296833&chksm=8a0f495e1bf34e32bdd0e087b3d55b6541aac5cd462a1dacdd8b0a2fc8e71fea61b44b2d1bb7&scene=27 £¨Accessed: September 28, 2025£©
3. Kayne, P. et al. (2025). Activating the Melanocortin System Resolves Inflammation, Reduces VEGF Signaling in Diabetic Retinopathy (DR), and Provides Retinal Ganglion Cell (RGC) Protection. Available at:https://palatin.com/wpcontent/uploads/2025/05/PosterPTN_PL9654_Diabetic_RetinopathyARVO_2025050825.pdf (Accessed: September 28, 2025)
4. Rossi, S., Maisto, R., Gesualdo, C., Trotta, M. C., Ferraraccio, F., Kaneva, M. K., Getting, S. J., Surace, E., Testa, F., Simonelli, F., Grieco, P., Merlino, F., Perretti, M., D'Amico, M., & Di Filippo, C. (2016). Activation of Melanocortin Receptors MC 1 and MC 5 Attenuates Retinal Damage in ExperimentalDiabeticRetinopathy. Mediatorsofinflammation,2016, 7368389. https://doi.org/10.1155/2016/7368389
5. Wang, S., Kahale, F., Naderi, A., Surico, P. L., Yin, J., Dohlman, T., Chen, Y., & Dana, R. (2024). Therapeutic Effects of Stimulating the Melanocortin Pathway in Regulating Ocular Inflammation and Cell Death.Biomolecules,14(2),169. https://doi.org/10.3390/biom14020169
Ïà¹ØÍƼö
ÍøÕ¾½¨É裺ÖÐÆó¶¯Á¦ ̨ÖÝ